Global Industry Analysts, Inc., Sep 2011, Pages: 794
DiagnosticsTest Development in Cancer 47
Clovis Oncology and Roche to Develop Companion Diagnostics for
NSCLC
Global Industry Analysts, Inc., Oct 2010, Pages: 659
This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening.
The report
TriMark Publications, July 2011, Pages: 214
and Market Share in Global Molecular Diagnostics Cancer Testing Market 31
Table 3.5: Business Factors Influencing Advanced OncologyTesting Services 32
Table 3.6: Specific Diagnostic Products Categories Comprising
Bizacumen Inc., Nov 2009, Pages: 277
: Percentage Breakdown of Leading Players in the
Worldwide Genetic Testing Market - 2006
Table 5: Percentage Breakdown of Worldwide Cancer DiagnosticTesting Market - 2006
Table 6: Global Molecular Diagnostics
RNCOS E-Services Private Limited, Jan 2012, Pages: 65
As the foundation of providing superior healthcare lies in diagnosis, genetic testing represents a highly attractive segment in molecular diagnostics market. Genetic testing is a sophisticated form
Business Insights, Jan 2011, Pages: 130
” integrations with imaging.
Siemens is a global provider of medical diagnostic systems, incorporating primary tests and instrumentation, IT platforms and software solutions, for clinical data handling
Infiniti Research Limited, Feb 2010, Pages: 20
to lead to the development of high-value diagnostictests for oncology, cardiovascular , genetic and infectious diseases.
The report by TechNavio Insights forecasts the market size of the worldwide
TriMark Publications, May 2011, Pages: 3057
and marketing high-growth diagnostictesting technologies in the clinical hospital market. It defines the dollar volume of sales, both worldwide and in the U.S., of the market and analyzes the factors
Global Industry Analysts, Inc., Jan 2011, Pages: 354
Testing: The Rapidly Growing Segment of Molecular
Diagnostics Market
Table 1: Worldwide In-Vitro Diagnostics Market by Segment
(2008) - Percentage Breakdown of Value Sales for
Immunochemistry, Diabetes
Koncept Analytics, June 2011, Pages: 43
methods towards the molecular diagnostictests.
Presently, the molecular diagnostic market is growing on the back of oncology and the infectious disease segment, but in future, when these segments
Decision Resources, Inc., Dec 2006, Pages: 27
IVD (in vitro diagnostics) tests are essential to the practice of health care worldwide: an estimated 60-70% of medical decisions involve a diagnostictest. This report focuses on IVD industry deals
TriMark Publications, July 2011, Pages: 267
Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans
Global Industry Analysts, Inc., Oct 2011, Pages: 373
diagnostictests. More than 10,000 hospitals worldwide utilize radioisotopes for the in-vivo diagnosis or treatment of approximately 35 million patients every year. Radiopharmaceuticals in this regard
Jain PharmaBiotech, Feb 2012, Pages: 348
in animals
Veterinary cytogenetics
Applications of molecular diagnostics in animals
Canine DNA testingDiagnostic aids to selective breeding
Selection of desirable traits
Gene variations and fat content
Decision Resources, Inc., Dec 2009, Pages: 38
. The market for these targeted therapies is very attractive. Decision Resources Pharmaview analysts forecast that worldwide sales of targeted therapies will reach $56.3 billion in 2015, constituting 61.5% of the total oncology
Research Facts Ltd, July 2009, Pages: 55
technologies such as lab-on-a-chip.
There are many point-of-care diagnostics manufacturing companies worldwide. This report profiles the Top 20 for oncology. These are the companies with the experience, know
TriMark Publications, Jan 2011, Pages: 156
and supplies for performing cytology and related molecular diagnostictests, such as human papillomavirus (HPV) and other inflammatory and sexually-transmitted diseases. 1. Overview
1.1 Statement of Report
1
Research Facts Ltd, Aug 2010, Pages: 50
with experience in distributing high-complexity molecular diagnostictests in the oncology field, to identify the leading developers with the latest products.
4) Pharmaceutical & Biotechnology Companies
Axis Research Mind, Nov 2011, Pages: 342
Of Pcr Arrays
Doctrine Of Assay Corroboration For Nucleic Acid DiagnosticTests
Assay Corroboration – An Introduction
Selecting An Assay Fitting Its Intended Purpose
Considerations Towards Primitive
